Is a Carnitine Based Food Supplement (PorimoreTM) for Infertile Men Superior to Folate and Zinc With Regard to Pregnancy Rates in Intrauterine Insemination Cycles?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01075334|
Recruitment Status : Unknown
Verified February 2010 by Shaare Zedek Medical Center.
Recruitment status was: Recruiting
First Posted : February 25, 2010
Last Update Posted : February 25, 2010
|Condition or disease||Intervention/treatment||Phase|
|Male Infertility||Dietary Supplement: Porimore - A Carnitine based food supplement Dietary Supplement: Zinc and Folate Supplementation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||February 2010|
|Estimated Study Completion Date :||December 2012|
Experimental: Porimore arm
Infertile men will receive 'Porimore' tablets for a period of time in which three intrauterine insemination cycles will be performed.
Dietary Supplement: Porimore - A Carnitine based food supplement
A daily dose of 2 grams L-carnitine, 1 gr acetyl L-carnitine, 500mg Vitamin C, 400 IU vitamin E, 60 mg Q10, 30mg Zinc Picolinate, 500mcg Folic Acid, 200 Mcg Selenium, 100 MCG Vitamin B12.
|Active Comparator: Folate and Zinc||
Dietary Supplement: Zinc and Folate Supplementation
500 Mcg Folic acid, 30-60 mg Zinc tablets/ day
- Pregnancy Rate [ Time Frame: 3 Insemination cycles ]proportion of women becoming pregnancy following treatment with intrauterine insemination
- Sperm quality parameters [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01075334
|Contact: Avi Tsafrir, MDfirstname.lastname@example.org|
|Shaare-Zedek IVF and infertility unit||Recruiting|
|Jerusalem, Israel, 91031|
|Principal Investigator: Avi Tsafrir, MD|